IBC Consortium To Host First-Ever Annual Meeting (2.28.18)
In partnership with the Duke School of Medicine, Duke Cancer Institute, Duke Department of Surgery, and the IBC Network Foundation, the Duke Consortium for Inflammatory Breast Cancer (IBC) will host its first-ever Annual Meeting, “Engaging Our Community in IBC Research and Awareness,” on Wednesday, Feb. 28, from 8 a.m. to 1 p.m. at the Trent Semans Center, Sixth Floor, at Duke University in Durham, North Carolina.
Physicians, basic and clinical researchers, healthcare practitioners, patient advocates, caregivers, nurses and community stakeholders are invited to attend. Among the many presenters, Massimo Cristofanilli, MD, FACP, Northwestern University (president of IBC International Consortium); Naoto Ueno, MD, PhD, FACP, MD Anderson IBC Center; and Beth Overmoyer, MD, Dana-Farber Cancer Institute will also speak during the first session: Global Partnership In Clinical Management of IBC. Wendy Woodward, MD, PhD, MD Anderson Cancer Center, will present in the second session: Research Challenges and Opportunities in IBC. In addition, the program will include a conversation cafe style session: Working with Advocates and Community Partners.
Led by Gayathri Devi, PhD, and Paul Kelly Marcom, MD, The Duke Consortium for Inflammatory Breast Cancer is a multidisciplinary center of research innovation and clinical excellence that is focused on understanding, preventing, and treating inflammatory breast cancer through collaboration with our local, national and international partners. It's mission is to understand the challenges faced by patients and caregivers with this highly aggressive and often misdiagnosed type of breast cancer. Compared with other types of breast cancer, inflammatory breast cancer has a unique presentation and tends to be diagnosed at a younger age. African Americans are disporportionately at a higher risk of developing aggressive inflammatory breast cancer with poor outcomes.
The Consortium for Inflammatory Breast Cancer Annual Meeting coincides with International Rare Disease Day. Registration is required. To register, go to Consortium for IBC Annual Meeting. Lunch will be provided to registered participants. For more information, please contact Holly Hough at 919.684.6783.
Related IBC Paper: XIAP regulation by MNK links MAPK and NFkB signaling to determine an aggressive breast cancer phenotype. Cancer Research. 2018 Jan. 19. Evans MK, Brown MC, Geradts J, Bao X, Robinson TJ, Jolly JK, Vermeulen P, Palmer GM, Gromeier M, Levine H, Morse MA, Van Laere S, Devi GR.